Latest News for: Pharmaceutical sources

Edit

Eledon Pharmaceuticals to Present at Jefferies Healthcare Conference

Enid News & Eagle 02 Jun 2023
IRVINE, Calif., June 02, 2023 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc ... About Eledon Pharmaceuticals and tegoprubart (formerly AT-1501). Eledon Pharmaceuticals is a clinical stage biotechnology ... Follow Eledon Pharmaceuticals on social media ... Source. Eledon Pharmaceuticals.
Edit

Levolta Pharmaceuticals Partners with Tabuk Pharmaceuticals for Commercialization of Investigational Osteoarthritis Therapy in Middle East ...

Eagle-Tribune 02 Jun 2023
BETHLEHEM, Pa., June 1, 2023 /PRNewswire/ -- Levolta Pharmaceuticals, Inc ... "We are excited to announce this partnership with Tabuk Pharmaceuticals, as it represents the next step in bringing the first disease modifying therapy for osteoarthritis to market," said Levolta Chief Executive Officer (CEO) Richard P ... SOURCE Levolta Pharmaceuticals.
Edit

Syros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Eagle-Tribune 02 Jun 2023
Syros Pharmaceuticals (NASDAQ.SYRS), ... About Syros Pharmaceuticals ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20230601005849/en/ ... SCIENCE BIOMETRICS BIOTECHNOLOGY RESEARCH PHARMACEUTICAL ONCOLOGY HEALTH CLINICAL TRIALS. SOURCE. Syros Pharmaceuticals.
Edit

Signing of Exclusive Distributorship Agreement With EVERZOM

Enid News & Eagle 02 Jun 2023
Summit Pharmaceuticals International (Head Office ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20230602005106/en/ ... RESEARCH CLINICAL TRIALS BIOTECHNOLOGY OTHER HEALTH HEALTH PHARMACEUTICAL OTHER SCIENCE SCIENCE ONCOLOGY. SOURCE.
Edit

KalVista Pharmaceuticals to Present Data at the 2023 Meeting of the European Academy of Allergy ...

Tyler Morning Telegraph 02 Jun 2023
KalVista Pharmaceuticals, Inc ... About KalVista Pharmaceuticals, Inc. KalVista Pharmaceuticals, Inc. is a pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors for diseases with significant unmet need ... KalVista Pharmaceuticals, Inc.Jarrod Aldom ... SOURCE. KalVista Pharmaceuticals, Inc.
Edit

CANTEX PHARMACEUTICALS OBTAINS EXCLUSIVE WORLDWIDE RIGHTS TO INTELLECTUAL PROPERTY FROM GEORGETOWN UNIVERSITY FOR AZELIRAGON AS ...

Eagle-Tribune 02 Jun 2023
About Cantex Pharmaceuticals, Inc. Cantex Pharmaceuticals, Inc. is a privately held, clinical-stage pharmaceutical company focused on developing transformative therapies for cancer and other life-threatening medical conditions for which new treatments are urgently needed ... Cantex Pharmaceuticals, Inc ... SOURCE Cantex Pharmaceuticals, Inc.
Edit

CANbridge Announces Marketing Approval of CAN108 (迈芮倍®/LIVMARLI®) in China for the Treatment of Cholestatic Pruritus ...

The Joplin Globe 02 Jun 2023
CANbridge Pharmaceuticals, Inc ... CANbridge has an exclusive license with Mirum Pharmaceuticals, Inc ... “We are delighted to have received marketing approval for LIVMARLI in mainland China so soon after this novel treatment was approved in the leading Western markets,” said James Xue, Ph.D., founder, chairman and CEO of CANbridge Pharmaceuticals Inc.
Edit

Global Macular Degeneration Treatment Market Report 2023: Sector is Expected to Reach $1.9 Billion by ...

Tyler Morning Telegraph 02 Jun 2023
Companies MentionedAerie Pharmaceuticals Inc.Bausch Health Companies Inc.Bayer AGF. Hoffmann-La Roche LtdIveric Bio Inc.Novartis AGPanopticaPfizer Inc.Phio PharmaceuticalsRegeneron Pharmaceuticals Inc.Regenxbio Inc.Santen Pharmaceutical Co ... ResearchAndMarkets.com is the world's leading source for international market research reports and market data.
Edit

Savara to Present at the Jefferies Healthcare Conference

The Joplin Globe 02 Jun 2023
AUSTIN, Texas--(BUSINESS WIRE)--Jun 2, 2023--. Savara Inc. (Nasdaq ... About Savara ... More information can be found at www.savarapharma.com. (Twitter ... www.linkedin.com/company/savara-pharmaceuticals/ ). View source version on businesswire.com.https.//www.businesswire.com/news/home/20230602005016/en/ ... BIOTECHNOLOGY PHARMACEUTICAL HEALTH CLINICAL TRIALS. SOURCE ... .
Edit

Aldeyra Therapeutics to Participate in Fireside Chat at the Jefferies Global Healthcare Conference

Eagle-Tribune 02 Jun 2023
Our approach is to discover pharmaceuticals that modulate immunological systems, instead of directly inhibiting or activating single protein targets, with the goal of optimizing multiple pathways at once while minimizing toxicity ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20230602005049/en/ ... SOURCE.
Edit

TraceLink Ensures DSCSA Verification Readiness and End-to-End VRS Support for Pharmaceutical Supply Chain Members Amid ...

Eagle-Tribune 02 Jun 2023
TraceLink has been investing for over a decade in deploying solutions to help pharmaceutical companies and other members of the U.S. pharmaceutical supply chain meet serialization, traceability, verification, and other DSCSA requirements ... Pharmaceutical ... SOURCE TraceLink Inc.
Edit

Precision Cancer Consortium Teams Up with Massive Bio to Utilize AI Analytics and Enhance Clinical ...

The Joplin Globe 02 Jun 2023
By working together and utilizing a collection of genomics data from multiple sources centralized with the assistance of AI, we can create a valuable scientific resource and optimize the efficiency of clinical trial matching globally and scale." ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20230602005015/en/.
Edit

PharmaEssentia Selects Pint-Pharma as Commercial Partner for BESREMi® (ropeginterferon alfa-2b-njft) in Latin America

Eagle-Tribune 02 Jun 2023
Pint-Pharma is an Austria-based pharmaceutical company with extensive experience in registering and commercializing rare disease, oncology and specialty treatments throughout Latin America ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20230602005191/en/ ... BIOTECHNOLOGY OTHER HEALTH HEALTH PHARMACEUTICAL ONCOLOGY.
Edit

Affini-T Therapeutics Appoints Industry Veteran Thaminda Ramanayake, M.S., MBA, as Chief Business Officer

The Joplin Globe 02 Jun 2023
Mr ... Business Wire) ... Mr ... Ramanayake played a pivotal role at BioMarin Pharmaceutical, leading initiatives to fortify the rare diseases portfolio and establish new enterprises ... Mr ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20230602005071/en/ ... ONCOLOGY HEALTH GENETICS RESEARCH SCIENCE PHARMACEUTICAL BIOTECHNOLOGY. SOURCE.
Edit

AOP Health: Completed Study Strengthens Clinical Development Program for ropeginterferon alpha 2b (Besremi®) in polycythaemia vera

Eagle-Tribune 02 Jun 2023
Dr ... Studio Koekart ... Link. ... The AOP Health Group incorporates several companies including AOP Orphan Pharmaceuticals GmbH with its seat in Vienna, Austria (“AOP Health”) ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20230601005759/en/ ... ONCOLOGY HEALTH CLINICAL TRIALS RESEARCH SCIENCE PHARMACEUTICAL BIOTECHNOLOGY. SOURCE ... .

Most Viewed

School kid of Nara, Japan; May 2012
Creative Commons / John Gillespie from New York, USA
Cambodian dancers perform to mark the 71st founding anniversary of the Cambodian People's Party (CPP) at its headquarters in Phnom Penh, Cambodia, Tuesday, June 28, 2022
AP / Heng Sinith
×